canSAR
Names
More detailed information about this field from each metasource.
canSAR
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
CanSAR
metasource: Nucleic Acid Research database catalogue
version: extracted_at: 2022-11-04T11:16:25.468657
cansar
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
Names
More detailed information about this field from each metasource.
canSAR
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
CanSAR
metasource: Nucleic Acid Research database catalogueversion: extracted_at: 2022-11-04T11:16:25.468657
cansar
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
Names
More detailed information about this field from each metasource.
canSAR
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
CanSAR
metasource: Nucleic Acid Research database catalogueversion: extracted_at: 2022-11-04T11:16:25.468657
cansar
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
canSAR is an integrated cancer research and drug discovery resource that brings together large-scale data from different disciplines and allows query and exploration to help cancer research and drug discovery.
Description
More detailed information about this field from each metasource.
canSAR is an integrated cancer research and drug discovery resource that brings together large-scale data from different disciplines and allows query and exploration to help cancer research and drug discovery.
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
canSAR (http://cansar.icr.ac.uk) is the largest, public, freely available, integrative translational research and drug discovery knowledgebase for oncology. canSAR integrates vast multidisciplinary data from across genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and more. It also provides unique data, curation and annotation and crucially, AI-informed target assessment for drug discovery. canSAR is widely used internationally by academia and industry. Here we describe significant developments and enhancements to the data, web interface and infrastructure of canSAR in the form of the new implementation of the system: canSARblack. We demonstrate new functionality in aiding translation hypothesis generation and experimental design, and show how canSAR can be adapted and utilised outside oncology.
metasource: Nucleic Acid Research database catalogueversion: extracted_at: 2022-11-04T11:16:25.468657
canSAR is an integrated database that brings together biological, chemical, pharmacological (and eventually clinical) data. Its goal is to integrate this data and make it accessible to cancer research scientists from multiple disciplines, in order to help with hypothesis generation in cancer research and support translational research.
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
Webpage:
http://cansar.icr.ac.ukWebpage
More detailed information about this field from each metasource.
http://cansar.icr.ac.uk
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
metasource: Nucleic Acid Research database catalogue
version: extracted_at: 2022-11-04T11:16:25.468657
https://cansar.icr.ac.uk/
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
Licence:
Name: CANSAR Terms of UseLicence name
More detailed information about this field from each metasource.
CANSAR Terms of Use
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
Licence URL
More detailed information about this field from each metasource.
https://cansar.icr.ac.uk/cansar/terms-of-use/
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
canSAR: an updated cancer research and drug discovery knowledgebase
PMID: 26673713
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
canSAR: updated cancer research and drug discovery knowledgebase
PMID: 24304894
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
canSAR: an integrated cancer public translational research and drug discovery resource
PMID: 22013161
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
https://doi.org/10.1093/nar/gkaa1059
metasource: Nucleic Acid Research database catalogue
version: extracted_at: 2022-11-04T11:16:25.468657
Publications
More detailed information about this field from each metasource.
canSAR: an updated cancer research and drug discovery knowledgebase
PMID: 26673713
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
canSAR: updated cancer research and drug discovery knowledgebase
PMID: 24304894
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
canSAR: an integrated cancer public translational research and drug discovery resource
PMID: 22013161
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
https://doi.org/10.1093/nar/gkaa1059
metasource: Nucleic Acid Research database catalogueversion: extracted_at: 2022-11-04T11:16:25.468657
-
canSAR: an updated cancer research and drug discovery knowledgebase
PubMed citations: 41.
41 articles citing: canSAR: an updated cancer research and drug discovery knowledgebase
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner. PMID:35902728
Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines. PMID:35737245
Worldwide Protein Data Bank (wwPDB): A virtual treasure for research in biotechnology. PMID:34908533
A multi-omic single-cell landscape of human gynecologic malignancies. PMID:34739872
ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species. PMID:34597626
Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer. PMID:34572412
DES-Tcell is a knowledgebase for exploring immunology-related literature. PMID:34253812
Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues. PMID:34056582
Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer. PMID:33854036
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. PMID:33822745
Targeting pan-essential genes in cancer: Challenges and opportunities. PMID:33450197
canSAR: update to the cancer translational research and drug discovery knowledgebase. PMID:33219674
Binding of the Treslin-MTBP Complex to Specific Regions of the Human Genome Promotes the Initiation of DNA Replication. PMID:32966791
PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas. PMID:32727536
Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma. PMID:32707690
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities. PMID:32433464
Molecular Signatures of Fusion Proteins in Cancer. PMID:32219217
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation. PMID:31959764
PDBe-KB: a community-driven resource for structural and functional annotations. PMID:31584092
A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation. PMID:31372638
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR. PMID:31244651
Free Accessible Databases as a Source of Information about Food Components and Other Compounds with Anticancer Activity⁻Brief Review. PMID:30813234
Leveraging Human Genetics to Guide Cancer Drug Development. PMID:30652614
canSAR: update to the cancer translational research and drug discovery knowledgebase. PMID:30496479
ChEMBL: towards direct deposition of bioassay data. PMID:30398643
Analysis of impact metrics for the Protein Data Bank. PMID:30325351
Genomics, bio specimens, and other biological data: Current status and future directions. PMID:30226926
GEMiCCL: mining genotype and expression data of cancer cell lines with elaborate visualization. PMID:29726944
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. PMID:29662167
Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro. PMID:29643433
Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells. PMID:29348601
Objective, Quantitative, Data-Driven Assessment of Chemical Probes. PMID:29249694
Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR. PMID:28928368
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. PMID:28826504
A simple mathematical approach to the analysis of polypharmacology and polyspecificity data. PMID:28690829
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib. PMID:28566333
Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC). PMID:28099902
The 24th annual Nucleic Acids Research database issue: a look back and upcoming changes. PMID:28053160
A comprehensive map of molecular drug targets. PMID:27910877
The ChEMBL database in 2017. PMID:27899562
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening. PMID:27613601 -
canSAR: updated cancer research and drug discovery knowledgebase
PubMed citations: 40.
40 articles citing: canSAR: updated cancer research and drug discovery knowledgebase
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner. PMID:35902728
In silico comprehensive analysis of coding and non-coding SNPs in human mTOR protein. PMID:35788771
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. PMID:33822745
Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy. PMID:33450833
Tuning Local Hydration Enables a Deeper Understanding of Protein-Ligand Binding: The PP1-Src Kinase Case. PMID:33300337
canSAR: update to the cancer translational research and drug discovery knowledgebase. PMID:33219674
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches. PMID:32994435
PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas. PMID:32727536
Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing. PMID:31988837
Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma. PMID:30858165
canSAR: update to the cancer translational research and drug discovery knowledgebase. PMID:30496479
Drug Repurposing of Metabolic Agents in Malignant Glioma. PMID:30223473
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. PMID:29662167
Objective, Quantitative, Data-Driven Assessment of Chemical Probes. PMID:29249694
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer. PMID:29115931
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. PMID:28826504
Bioinformatics in translational drug discovery. PMID:28487472
CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice. PMID:28296354
Polypharmacology in Precision Oncology: Current Applications and Future Prospects. PMID:27669965
Screening out irrelevant cell-based models of disease. PMID:27616293
Drug discovery in advanced prostate cancer: translating biology into therapy. PMID:27444228
Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center. PMID:27082517
Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein. PMID:26863535
Distinctive Behaviors of Druggable Proteins in Cellular Networks. PMID:26699810
Identification of epistatic interactions through genome-wide association studies in sporadic medullary and juvenile papillary thyroid carcinomas. PMID:26690675
canSAR: an updated cancer research and drug discovery knowledgebase. PMID:26673713
CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs. PMID:26590406
Targeting mitochondrial RNA polymerase in acute myeloid leukemia. PMID:26484416
Single-Cell Genetic Analysis Using Automated Microfluidics to Resolve Somatic Mosaicism. PMID:26302375
Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer. PMID:26206335
A large-scale crop protection bioassay data set. PMID:26175909
Therapeutic opportunities within the DNA damage response. PMID:25709118
Databases and web tools for cancer genomics study. PMID:25707591
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma. PMID:25609060
Cancer3D: understanding cancer mutations through protein structures. PMID:25392415
Human cancer databases (review). PMID:25369839
ComPPI: a cellular compartment-specific database for protein-protein interaction network analysis. PMID:25348397
EMBO conference series: Chemical Biology 2014. PMID:25318996
Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors. PMID:25310149
What's that gene (or protein)? Online resources for exploring functions of genes, transcripts, and proteins. PMID:24723265 -
canSAR: an integrated cancer public translational research and drug discovery resource
PubMed citations: 34.
34 articles citing: canSAR: an integrated cancer public translational research and drug discovery resource
Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells. PMID:35845599
Advanced Diagnostic Technology of Volatile Organic Compounds Real Time analysis Analysis From Exhaled Breath of Gastric Cancer Patients Using Proton-Transfer-Reaction Time-of-Flight Mass Spectrometry. PMID:33996531
Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy. PMID:33450833
KIAA0101 as a new diagnostic and prognostic marker, and its correlation with gene regulatory networks and immune infiltrates in lung adenocarcinoma. PMID:33231570
canSAR: update to the cancer translational research and drug discovery knowledgebase. PMID:33219674
Systems Biology and Experimental Model Systems of Cancer. PMID:33086677
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities. PMID:32433464
Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing. PMID:31988837
Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma. PMID:30858165
canSAR: update to the cancer translational research and drug discovery knowledgebase. PMID:30496479
Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis. PMID:29237412
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer. PMID:29115931
Drug Target Protein-Protein Interaction Networks: A Systematic Perspective. PMID:28691014
CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice. PMID:28296354
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells. PMID:27551077
Distinctive Behaviors of Druggable Proteins in Cellular Networks. PMID:26699810
canSAR: an updated cancer research and drug discovery knowledgebase. PMID:26673713
Leveraging big data to transform target selection and drug discovery. PMID:26659699
Dealing with the Data Deluge: Handling the Multitude Of Chemical Biology Data Sources. PMID:26609498
Targeting tumor suppressor genes for cancer therapy. PMID:26445307
Targeted therapies in bladder cancer: an overview of in vivo research. PMID:26390971
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer. PMID:26311743
TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples. PMID:25638808
Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview. PMID:25584743
Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer. PMID:24459064
canSAR: updated cancer research and drug discovery knowledgebase. PMID:24304894
Drugging cancer genomes. PMID:24287764
The ChEMBL bioactivity database: an update. PMID:24214965
Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles. PMID:23530504
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. PMID:23361103
Objective assessment of cancer genes for drug discovery. PMID:23274470
Reuse of public genome-wide gene expression data. PMID:23269463
Combinatorial drug therapy for cancer in the post-genomic era. PMID:22781697
Discovery of small molecule cancer drugs: successes, challenges and opportunities. PMID:22440008 - https://doi.org/10.1093/nar/gkaa1059
Tags:
Tags
More detailed information about this field from each metasource.
annotation
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
cancer
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
cellular assay
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
chemical screen
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
chemical structure
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
drug binding
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
drug report
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
gene expression data
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
rnai screening
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
structure
metasource: Fairsharing.org
version: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
human genes and diseases
metasource: Nucleic Acid Research database catalogue
version: extracted_at: 2022-11-04T11:16:25.468657
cancer gene databases
metasource: Nucleic Acid Research database catalogue
version: extracted_at: 2022-11-04T11:16:25.468657
drug discovery
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
small molecules
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
oncology
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
medicinal chemistry
metasource: bio.tools
version: extracted_at: 2022-11-04T11:35:15.045032
Tags
More detailed information about this field from each metasource.
annotation
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
cancer
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
cellular assay
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
chemical screen
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
chemical structure
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
drug binding
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
drug report
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
gene expression data
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
rnai screening
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
structure
metasource: Fairsharing.orgversion: FAIRsharing.org: canSAR; canSAR; DOI: https://doi.org/10.25504/FAIRsharing.nj4vca; Last edited: Jan. 8, 2019, 1:12 p.m.; Last accessed: Jan 03 2022 7:08 p.m.
human genes and diseases
metasource: Nucleic Acid Research database catalogueversion: extracted_at: 2022-11-04T11:16:25.468657
cancer gene databases
metasource: Nucleic Acid Research database catalogueversion: extracted_at: 2022-11-04T11:16:25.468657
drug discovery
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
small molecules
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
oncology
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
medicinal chemistry
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:35:15.045032
cancer cellular assay chemical screen chemical structure drug binding drug report gene expression rnai screening structure human genes and diseases cancer-related genes drug discovery small molecule oncology medicinal chemistry
Need help integrating and/or managing biomedical data?